In vitro and in vivo bimodal effects of docosahexaenoic acid supplements on redox status and platelet function
- 13 July 2016
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 138, 60-63
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dose-effect and metabolism of docosahexaenoic acid: Pathophysiological relevance in blood plateletsProstaglandins, Leukotrienes and Essential Fatty Acids, 2013
- Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregationThe FASEB Journal, 2010
- Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy menAtherosclerosis, 2010
- Increasing intakes of the long‐chain ω‐3 docosahexaenoic acid: effects on platelet functions and redox status in healthy menThe FASEB Journal, 2009
- Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosisBritish Journal of Nutrition, 2008
- Oxidant Stress and Platelet Activation in HypercholesterolemiaAntioxidants & Redox Signaling, 2004
- Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular DiseaseCirculation, 2002
- The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteersBritish Journal of Nutrition, 1992
- Different metabolic behavior of long-chain n−3 polyunsaturated fatty acids in human plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscleBiochemical Pharmacology, 1988